Paper39025943
Radiotherapy-triggered reduction of platinum-based chemotherapeutic prodrugs in tumours.
Fu Q and 12 others. Nat Biomed Eng, 2024. Cited by 50 papers, by iCite.
Cite this record
ConductScience Library. Radiotherapy-triggered reduction of platinum-based chemotherapeutic prodrugs in tumours. Papers, record 39025943. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39025943
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Prodrugs | Major topic |
| Antineoplastic Agents | Major topic |
| Animals | |
| Humans | |
| Mice | |
| Cell Line, Tumor | |
| Platinum | |
| Xenograft Model Antitumor Assays | |
| Neoplasms | |
| Oxaliplatin | |
| Female | |
| Trastuzumab | |
| Mice, Nude | |
| Organoplatinum Compounds | |
| Tumor Microenvironment |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 22225603 | National Natural Science Foundation of China (National Science Foundation of China) | PubMed | ||
| 21731004 | National Natural Science Foundation of China (National Science Foundation of China) | PubMed | ||
| 91953201 | National Natural Science Foundation of China (National Science Foundation of China) | PubMed | ||
| 2021YFA1601400 | Ministry of Science and Technology of the People's Republic of China (Chinese Ministry of Science and Technology) | PubMed | ||
| Z200018 | Natural Science Foundation of Beijing Municipality (Beijing Natural Science Foundation) | PubMed |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 42722903 | Author Correction: Radiotherapy-triggered reduction of platinum-based chemotherapeutic prodrugs in tumours. | https://conductscience.org/library/papers/42722903 |
Source PubMed
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32843739 | Artificial intelligence in radiation oncology. | Nat Rev Clin Oncol | 2020 | https://conductscience.org/library/papers/32843739 | PubMed |
| 2 | 30792503 | Radiotherapy toxicity. | Nat Rev Dis Primers | 2019 | https://conductscience.org/library/papers/30792503 | PubMed |
| 3 | 15170446 | Exploiting tumour hypoxia in cancer treatment. | Nat Rev Cancer | 2004 | https://conductscience.org/library/papers/15170446 | PubMed |
| 4 | 26105538 | The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. | Nat Rev Cancer | 2015 | https://conductscience.org/library/papers/26105538 | PubMed |
| 5 | 14645636 | Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. | N Engl J Med | 2003 | https://conductscience.org/library/papers/14645636 | PubMed |
| 6 | 24889915 | Review of therapeutic drug monitoring of anticancer drugs part 1--cytotoxics. | Eur J Cancer | 2014 | https://conductscience.org/library/papers/24889915 | PubMed |
| 7 | 29700501 | The expanding role of prodrugs in contemporary drug design and development. | Nat Rev Drug Discov | 2018 | https://conductscience.org/library/papers/29700501 | PubMed |
| 8 | 26865551 | The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs. | Chem Rev | 2016 | https://conductscience.org/library/papers/26865551 | PubMed |
| 9 | 19711978 | Platinum drug distribution in cancer cells and tumors. | Chem Rev | 2009 | https://conductscience.org/library/papers/19711978 | PubMed |
| 10 | 30299085 | Stimuli-Responsive Therapeutic Metallodrugs. | Chem Rev | 2019 | https://conductscience.org/library/papers/30299085 | PubMed |
| 11 | 22248856 | Reductive activation of 5-fluorodeoxyuridine prodrug possessing azide methyl group by hypoxic X-irradiation. | Bioorg Med Chem Lett | 2012 | https://conductscience.org/library/papers/22248856 | PubMed |
| 12 | 34112990 | Switching on prodrugs using radiotherapy. | Nat Chem | 2021 | https://conductscience.org/library/papers/34112990 | PubMed |
| 13 | 35594148 | Radiotherapy Reduces N-Oxides for Prodrug Activation in Tumors. | J Am Chem Soc | 2022 | https://conductscience.org/library/papers/35594148 | PubMed |
| 14 | 31919219 | Observation of the fastest chemical processes in the radiolysis of water. | Science | 2020 | https://conductscience.org/library/papers/31919219 | PubMed |
| 15 | 12767396 | Decomposition of an aqueous solution of [11C]Ro 15-4513: implication of hydrated electrons in the radiolysis of [11C]Ro 15-4513. | Nucl Med Biol | 2003 | https://conductscience.org/library/papers/12767396 | PubMed |
| 16 | 29048884 | Nanotechnology for Multimodal Synergistic Cancer Therapy. | Chem Rev | 2017 | https://conductscience.org/library/papers/29048884 | PubMed |
| 17 | 23042411 | Targeting and delivery of platinum-based anticancer drugs. | Chem Soc Rev | 2013 | https://conductscience.org/library/papers/23042411 | PubMed |
| 18 | 32216337 | A Photocaged, Water-Oxidizing, and Nucleolus-Targeted Pt(IV) Complex with a Distinct Anticancer Mechanism. | J Am Chem Soc | 2020 | https://conductscience.org/library/papers/32216337 | PubMed |
| 19 | 29509010 | Insight into the Electrochemical Reduction Mechanism of Pt(IV) Anticancer Complexes. | Inorg Chem | 2018 | https://conductscience.org/library/papers/29509010 | PubMed |
| 20 | 24853204 | Understanding intrinsically irreversible, non-Nernstian, two-electron redox processes: a combined experimental and computational study of the electrochemical activation of platinum(IV) antitumor prodrugs. | J Am Chem Soc | 2014 | https://conductscience.org/library/papers/24853204 | PubMed |
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 50 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42958328 | A platinum-osmium hybrid nanozyme potentiates chemo-radio-immunotherapy for colorectal cancer via tumor microenvironment remodeling and cGAS-STING activation. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/42958328 | PubMed |
| 42592132 | Nanocarrier-based delivery of Pt(IV) compounds for chemoimmunotherapy and theranostics: Advances, challenges, and prospects. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/42592132 | PubMed |
| 42503675 | Spontaneous Intracellular Formation of Covalent Organic Frameworks via Enzyme-Initiated Cascade Reactions to Boost Cancer Radiotherapy. | J Am Chem Soc | 2026 | https://conductscience.org/library/papers/42503675 | PubMed |
| 42500932 | A Multiple Enzyme-Mimetic Platinum-Ruthenium Nanohybrid Prodrug Potentiates Chemo-/Chemodynamic-/Immuno-Therapy of Hypoxic Tumors. | Adv Healthc Mater | 2026 | https://conductscience.org/library/papers/42500932 | PubMed |
| 42255197 | Uncoupling tumor immunogenicity from cell death with platinum(IV)-antibody conjugates. | Natl Sci Rev | 2026 | https://conductscience.org/library/papers/42255197 | PubMed |
| 42078200 | Radiotherapy meets anticancer metallodrugs. | Med Rev (2021) | 2026 | https://conductscience.org/library/papers/42078200 | PubMed |
| 42001063 | Single-dose X-ray driven persistent activation of nanoprodrugs for radio-chemo-immunotherapy. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/42001063 | PubMed |
| 41821152 | Engineering MnPt Bimetallic Nanozymes for Cascade Enzymatic Therapy and Enhanced Radio-Immunotherapy. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41821152 | PubMed |
| 41516303 | Lanthanide Nanotheranostics in Radiotherapy. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41516303 | PubMed |
| 41398312 | The role of ionizing radiation-initiated reactions in targeted activation of chemotherapeutics. | Nat Rev Chem | 2026 | https://conductscience.org/library/papers/41398312 | PubMed |
| 41332239 | Ruthenium Complexes in Protein Science: Heading a New Generation of Therapeutic and Analytical Tools. | Angew Chem Int Ed Engl | 2026 | https://conductscience.org/library/papers/41332239 | PubMed |
| 41202204 | Rate-Tunable, Metal-Mediated Amide Bond Cleavage for the Controlled Release of Pharmaceuticals. | J Am Chem Soc | 2025 | https://conductscience.org/library/papers/41202204 | PubMed |
| 41121609 | Controlled Dual Activation of Rhenium(I) Photosensitizers and Profluorophores/Prodrugs via a Dissociative Bioorthogonal Tetrazine-Isonitrile Reaction. | Angew Chem Int Ed Engl | 2025 | https://conductscience.org/library/papers/41121609 | PubMed |
| 40985211 | Colorectal Cancer at the Crossroads: The Good, the Bad, and the Future of Platinum-Based Drugs. | Chem Rev | 2025 | https://conductscience.org/library/papers/40985211 | PubMed |
| 40927152 | Improving Brain Tumor Treatment through Nanotechnology and Proton Therapy Using Laser-driven Accelerators through GEANT4 Simulation. | Indian J Nucl Med | 2025 | https://conductscience.org/library/papers/40927152 | PubMed |
| 40893960 | Radiotherapy-Activated Prodrug: Past, Present and Beyond. | ACS Cent Sci | 2025 | https://conductscience.org/library/papers/40893960 | PubMed |
| 40747318 | Novel tryptophan 2,3-dioxygenase-targeted ruthenium(ii)-indole complex activates immunotherapy in vitro and in vivo. | Chem Sci | 2025 | https://conductscience.org/library/papers/40747318 | PubMed |
| 40592827 | Single atom engineering for radiotherapy-activated immune agonist prodrugs. | Nat Commun | 2025 | https://conductscience.org/library/papers/40592827 | PubMed |
| 40563367 | Oxidative Stress and Inflammation: Drivers of Tumorigenesis and Therapeutic Opportunities. | Antioxidants (Basel) | 2025 | https://conductscience.org/library/papers/40563367 | PubMed |
| 40177396 | Alkyl Chloride-Functionalized Polymers Mediate Oxidation of Thioethers Initiated by Ionizing Radiation. | ACS Appl Polym Mater | 2025 | https://conductscience.org/library/papers/40177396 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39025943
GET https://conductscience.org/api/papers/v1/39025943/references?page=2